https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/accounts-payable https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/accounts-receivable https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/accrued-liabilities-current https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/accrued-professional-fees-current https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/accumulated-depreciation https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/amended-reports-10-k https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/amended-reports-10-k405 https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/amended-reports-10-q https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/amortization https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/assets-fair-value-disclosure https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/basic-shares https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/business-acquisition-cost-of-acquired-entity-cash-paid https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/buybacks-share-repurchases https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/capital-expenditures https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/cash-and-equivalents https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/cash-and-restricted-cash https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/cash-change https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/cash-collateral-for-borrowed-securities https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/cash-flow-breakdown https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/clinical-trials https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/common-stock-no-par-value https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/common-stock-value https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/comprehensive-income https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/comprehensive-income-net-of-tax-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/congressional-trades-other https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/contract-liability https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/contractual-obligation https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/contractual-obligation-due-in-fourth-year https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/contractual-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/contractual-obligation-due-in-second-year https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/contractual-obligation-due-in-third-year https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/conversion-of-stock-shares-converted https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/convertible-preferred-stock-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/cost-of-revenue https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/costs-and-expenses https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/cover-page-shares-outstanding https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/cumulative-effect-of-new-accounting-principle-in-period-of-adoption https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/current-assets https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/current-liabilities https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/debt-face-amount https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/deferred-rent-credit https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/deferred-rent-credit-current https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/deferred-revenue https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/deferred-tax-assets-capital-loss-carryforwards https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/deferred-tax-assets-gross https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/deferred-tax-assets-net https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/depreciation https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/derivative-gain-loss-on-derivative-net https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/derivative-liabilities-current https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/diluted-shares https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/dilutive-shares https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/dividends-preferred-stock-paidinkind https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/dividends-preferred-stock-stock https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/embedded-derivative-fair-value-of-embedded-derivative-net https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/embedded-derivative-gain-loss-on-embedded-derivative-net https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/employee-benefits-and-share-based-compensation-noncash https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/employee-related-liabilities-current https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/eps https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/eps-basic https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/financial-liabilities-fair-value-disclosure https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/financing-cash-flow https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/form-d-other https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/form-d-stocks https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/general-and-administrative-expense https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/goodwill https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/goodwill-and-intangible-asset-impairment https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/impairment-of-long-lived-assets-to-be-disposed-of https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/income-tax https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/income-tax-examination-interest-accrued https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/income-tax-examination-penalties-and-interest-accrued https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/income-tax-examination-penalties-and-interest-expense https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/increase-decrease-in-derivative-liabilities https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/increase-decrease-in-employee-related-liabilities https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/increase-decrease-in-fair-value-of-unhedged-derivative-instruments https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/increase-decrease-in-inventories https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/increase-decrease-in-inventories-and-other-operating-assets https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/increase-decrease-in-prepaid-expenses-other https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/increase-decrease-in-restricted-cash-and-investments-for-operating-activities https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/increase-decrease-in-restricted-cash-for-operating-activities https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/incremental-common-shares-attributable-to-conversion-of-preferred-stock https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/insider-transactions-other https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/insider-transactions-other/purchases https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/insider-transactions-preferred https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/insider-transactions-stock-options https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/insider-transactions-stock-units https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/insider-transactions-warrants https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/interest-and-dividends-payable-current-and-noncurrent https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/interest-expense https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/interest-expense-borrowings https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/interest-expense-other https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/interest-income-expense-net https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/interest-income-other https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/interest-paid https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/interest-paid-capitalized https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/inventory https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/inventory-valuation-reserves https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/inventory-write-down https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/investing-cash-flow https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/investment-sold-not-yet-purchased-sale-proceeds https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/investments-and-cash https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/lease-and-rental-expense https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/lease-cost https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/leasehold-improvements-gross https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/license-costs https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/net-cash-from-financing-activities https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/net-change-in-cash https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/net-income https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/non-hedging-derivatives-gain-loss-net https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/noncash-or-part-noncash-divestiture-amount-of-consideration-received https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/notes-payable-current https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/number-of-operating-segments https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/operating-cash-flow https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/operating-costs-and-expenses https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/operating-income https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/operating-lease-assets https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/operating-lease-liability https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/operating-lease-liability-current https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/operating-lease-payments https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/operating-lease-payments-due https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/operating-lease-payments-due-2 https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/operating-lease-payments-due-current https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/operating-lease-payments-due-future-minimum-sublease-rentals https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/other-accrued-liabilities-current https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/other-assets https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/other-noncurrent-liabilities https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/other-nonoperating-income-expense https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/paid-in-capital-increase-in-carrying-amount-of-redeemable-preferred-stock https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/paid-in-capital-stock-split https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/payments-for-restructuring https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/payments-of-dividends-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/payments-to-acquire-short-term-investments https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/preferred-shares-facts https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/preferred-stock-dividend-rate-percentage https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/preferred-stock-liquidation-preference https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/preferred-stock-shares-authorized https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/preferred-stock-shares-issued https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/preferred-stock-value https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/prepaid-insurance https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/pretax-income https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/proceeds-from-repayments-of-restricted-cash-financing-activities https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/proceeds-from-sale-of-short-term-investments https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/proceeds-from-stock-issued https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/property-plant-and-equipment-gross https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/property-plant-equipment https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/public-float https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/related-party-transaction-other-revenues-from-transactions-with-related-party https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/research-and-development https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/research-and-development-expense-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/restricted-cash https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/restricted-cash-current https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/restricted-cash-noncurrent https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/restricted-stock-expense https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/restructuring-charges https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/restructuring-costs https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/retained-earnings https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/revenue https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/revenue-from-related-parties https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-comment-letters-corresp https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-comment-letters-upload https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-filings-10-k https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-filings-10-k405 https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-filings-10-q https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-filings-15-12g https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-filings-25-nse https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-filings-425 https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-filings-8-a12b https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-filings-8-a12g https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-filings-8-k12b https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-filings-ars https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-filings-certnas https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-filings-ct-order https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-filings-def-14a https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-filings-def-14c https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-filings-defa14a https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-filings-defr14a https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-filings-pre-14a https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-filings-pre-14c https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-filings-prer14a https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-filings-regdex https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-filings-s-4 https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-filings-sc-14d9 https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-filings-sc-to-c https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-filings-sc-to-t https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sec-filings-sc14d9c https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/secondary-offerings-form-424b1 https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/secondary-offerings-form-424b2 https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/secondary-offerings-form-effect https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/secondary-offerings-form-s-3mef https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/sga-expense https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/shareholders-equity https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/shares-authorized https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/shares-issued https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/shares-issued-2 https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/shares-issued-shares-reverse-stock-splits https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/short-term-investments https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-award-rsu-vested-in-period-grant-date-fair-value https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-based-compensation https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-issued-new-shares-sold https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-issued-shares-issued-shares-espps https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-issued-shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-issued-shares-issued-value-stock-dividend https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-option-plan-expense https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-options-exercisable-number https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-options-grants-in-period https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-options-outstanding-change-average-exercise-price https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-options-outstanding-number https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-options-vested-grant-date-fair-value https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-redeemed-or-called-value https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/stock-split-ratio https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/subsequent-event-amount https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/tax-reconciliation-other-reconciling-items https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/temporary-equity-carrying-amount https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/temporary-equity-dividends-adjustment https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/temporary-equity-issue-period-increase-or-decrease https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/temporary-equity-redemption-value https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/temporary-equity-shares-authorized https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/temporary-equity-shares-issued https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/total-assets https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/total-liabilities https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/total-liabilities-and-equity https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/total-long-term-debt https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/unrealized-gain-loss-on-derivatives https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/unrecognized-tax-benefits https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/valuation-allowance-amount https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/warrants-and-rights-outstanding https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/weighted-average-number-of-shares-outstanding-basic-and-diluted https://stock.noler.com/us/stock/la-jolla-pharmaceutical-co/weighted-average-number-of-shares-restricted-stock